îæ€çŽ¢
îæ€çŽ¢
î
BioLine RX Ltd
BLRXîãŠã©ãããªã¹ãã«è¿œå
1.300USD
-0.050-3.70%
çµå€Â 11-13 16:00ïŒETïŒ
6.47Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
æ¬æ¥
-3.70%
5æ¥é
-23.98%
1ã¶æ
-37.35%
6ã¶æ
-57.52%
幎åæ¥
-53.07%
1幎é
-59.75%
äž»èŠããŒã¿
1.370å§å€
1.540é«å€
600.00åºæ¥é«
æ倱é¡çŽè¿12ã¶æPER
æ倱é¡äºæ³PER
--çŽè¿12ã¶æé
åœ
0.01%売買å転ç
1.350åæ¥çµå€
1.300å®å€
825.00売買代é
æ倱é¡æ ªäŸ¡åçç
0.49PBRïŒæ ªäŸ¡çŽè³ç£åçïŒ
0.00%çŽè¿12ã¶æé
åœå©åã
-5.08%ç·è³ç£å©çç
3.95052é±é«å€
0.05åºæ¥é«æ¯ç%
-9.22MçŽå©ç
4.98Mæ ªåŒæ°
-0.49201æ ªåœããå©çïŒEPSïŒ
1.49ããŒã¿å€
-12.80%èªå·±è³æ¬å©çç
1.30052é±å®å€
18.52%æ¯ãå¹
80.03%ç²å©çç
6.47Mæ䟡ç·é¡
-0.67ãªã¹ã¯ãªã¿ãŒã³
3.83%ãªã¹ã¯ç
ææ°æ
å ±ããåŸ
ã¡ãã ãã...
BioLine RX Ltdã®ã¹ã³ã¢î°î°
0.44ååå€ã«å¯Ÿããæ¯ç
äºæž¬å€8.00
財åå¥å
šæ§5.83
ãã¯ãã«ã«5.39
ããªã¥ãšãŒã·ã§ã³9.91
æ©é¢æè³å®¶ã®ä¿¡é Œæ3.00
ãªã¹ã¯è©äŸ¡3.11
ã¡ãã£ã¢å ±é
å ±éã¬ãã«
éåžžã«äœã
éåžžã«é«ã
äžç«
ã¢ããªã¹ãè©äŸ¡î
BioLine RX Ltd ãã¯ãã«ã«åæ
îãã¯ãã«ã«ææš
匷å売ãæšå¥š
èŠçŽ
売ã
移åå¹³å
匷å売ãæšå¥š
財åææšî
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
財åè«žè¡šî
次åå ±åæ¥
--
å ±åæé
2026Q2
財åè«žè¡š / äºæž¬
-0.68/0.00
åç / äºæž¬
294.00K/292.00K
BioLine RX Ltd ãããã£ãŒã«î
ã»ã¯ã¿ãŒãã€ãªãã¯ãããžãŒ & å»çç 究
äŒæ¥ã³ãŒãBLRX
åŸæ¥å¡æ°28
åœIsrael
ä¿æç¶æ³î
| æ ªäž»çµ±èš | æ¯ç |
|---|---|
| Hong Seng Technology Ltd | 3.92% |
| Citadel Advisors LLC | 0.84% |
| Intracoastal Capital, L.L.C. | 0.07% |
| Rhumbline Advisers Ltd. Partnership | 0.05% |
| çš®é¡ | æ¯ç |
|---|---|
| Corporation | 4.00% |
| Hedge Fund | 0.84% |
| Research Firm | 0.12% |
| Investment Advisor | 0.10% |
é¢é£éèåå
+1.26%
+0.79%
+0.20%
+0.55%
+0.16%
+0.04%
-0.30%
+0.08%
+2.41%
+0.21%
-0.74%
+1.78%
+2.39%
-0.19%
+0.52%
+0.45%
-3.45%
+1.47%
+1.06%
-2.17%人æ°éæ
î
52374.200
+21.400Â (+0.04%)
28113.300
+166.000Â (+0.59%)
7577.500
+14.300Â (+0.19%)
12797.000
-1.000Â (-0.01%)
61254.000
+258.000Â (+0.42%)
6416.400
+13.700Â (+0.21%)
87.346
-0.681Â (-0.77%)
356.270
+1.390Â (+0.39%)
162.850
-3.340Â (-2.01%)
3884.790
+6.570Â (+0.17%)
ãããã質å
BioLine RX LtdïŒBLRXïŒã®çŸåšã®æ ªäŸ¡ã¯ãããã§ããïŒ
îBioLine RX LtdïŒBLRXïŒã®çŸåšã®æ ªäŸ¡ã¯1.30ã§ãã
BioLine RX Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯äœã§ããïŒ
îBioLine RX Ltdã®ãã£ãã«ãŒã·ã³ãã«ã¯BLRXã§ãã
BioLine RX Ltdã®52é±é«å€ã¯ãããã§ããïŒ
îBioLine RX Ltdã®52é±é«å€ã¯3.95ã§ãã
BioLine RX Ltdã®52é±å®å€ã¯ãããã§ããïŒ
îBioLine RX Ltdã®52é±å®å€ã¯1.30ã§ãã
BioLine RX Ltdã®æ䟡ç·é¡ã¯ãããã§ããïŒ
îBioLine RX Ltdã®æ䟡ç·é¡ã¯6.47Mã§ãã
BioLine RX Ltd (BLRX) ã®çŸåšã®è©äŸ¡ã¯ãè²·ããããããŒã«ãããã売ããã®ã©ãã§ããïŒ
îã¢ããªã¹ãã«ãããšãBioLine RX LtdïŒBLRXïŒã®ç·åè©äŸ¡ã¯è²·ãã§ãç®æšæ ªäŸ¡ã¯22.00ã§ãã
BioLine RX Ltd (BLRX) ã®1æ ªåœããå©çïŒEPS TTMïŒã¯ãããã§ããïŒ
îBioLine RX LtdïŒBLRXïŒã®1æ ªåœããå©çïŒEPS TTMïŒã¯-0.49ã§ãã